Skip to main content
Equibles

JANUS HENDERSON GROUP PLC

Position in TGTX — Tg Therapeutics, Inc.

CIK 1274173 LONDON, X0
Back to TGTX Full portfolio

Position in TGTX

as of Mar 31, 2026 · filed May 18, 2026
Position Value
$2,137,938
+$219,456 QoQ
Shares Held
64,357
0.0% QoQ
Ownership
0.042%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in TGTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

JANUS HENDERSON GROUP PLC holds $15,214,395,751 across 183 Biotechnology names. TGTX ranks #97 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 2,541,732 $1,856,099,791
2 PRAX
Praxis Precision Medicines, Inc.
 3,458,863 $1,114,411,067
3 MDGL
Madrigal Pharmaceuticals, Inc.
 2,018,647 $1,056,701,142
4 BBIO
BridgeBio Pharma, Inc.
 13,179,013 $978,673,503
5 PCVX
Vaxcyte, Inc.
 16,575,875 $963,224,094
6 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,131,527 $951,812,064
7 RVMD
Revolution Medicines, Inc.
 9,766,496 $949,791,733
8 MIRM
Mirum Pharmaceuticals, Inc.
 6,945,813 $641,654,204

All Filings in TGTX

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $2,137,938 64,357
2025-12-31 $1,918,482 64,357
2025-09-30 $2,324,896 64,357
2025-06-30 $2,316,207 64,357
2025-03-31 $2,537,596 64,357
2024-12-31 $1,937,145 64,357
2024-09-30 $1,505,310 64,357
2024-06-30 $1,144,911 64,357
2024-03-31 $989,181 65,035
2023-12-31 $1,110,644 65,026
2023-09-30 $544,787 65,166
2023-06-30 $1,618,374 65,152
2023-03-31 $980,833 65,215
2022-12-31 $282,961 23,919
2022-09-30 $141,606 23,920
2022-06-30 $101,668 23,922
2022-03-31 $227,241 23,895
2021-12-31 $453,530 23,870
2021-09-30 $394,933 11,867